Biological Diagnosis of Depression: A Biomarker Panel from Several Nonspecial Indicators Instead of the Specific Biomarker(s)

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fifth ed. American Psychiatric Association; 2013.
   Google Scholar
• World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 11th Revision. World Health Organization; 2018.
   Google Scholar
• Regier DA, Narrow WE, Clarke DE, et al. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry. 2013;170(1):59–70. doi:10.1176/appi.ajp.2012.12070999
   PubMed Web of Science ®Google Scholar
• Fried EI, Epskamp S, Nesse RM, Tuerlinckx F, Borsboom D. What are ‘good’ depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis. J Affect Disord. 2016;189:314–320. doi:10.1016/j.jad.2015.09.005
   PubMed Web of Science ®Google Scholar
• Snyder R, Liebman LS, Simon AB, Kellner CH. Does heterogeneity of depression diagnosis harm those with severe mood disorders? Med Hypotheses. 2013;81(2):316–318. doi:10.1016/j.mehy.2013.04.011
   Web of Science ®Google Scholar
• Insel TR, Landis SC. Twenty-five years of progress: the view from NIMH and NINDS. Neuron. 2013;80(3):561–567. doi:10.1016/j.neuron.2013.09.041
   PubMed Web of Science ®Google Scholar
• Uher R, Farmer A, Maier W, et al. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med. 2008;38(2):289–300. doi:10.1017/S0033291707001730
   PubMed Web of Science ®Google Scholar
• Strawbridge R, Young AH, Cleare AJ. Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatr Dis Treat. 2017;13:1245–1262. doi:10.2147/NDT.S114542
   PubMed Web of Science ®Google Scholar
• Gadad BS, Jha MK, Czysz A, et al. Peripheral biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks. J Affect Disord. 2018;233:3–14. doi:10.1016/j.jad.2017.07.001
   PubMed Web of Science ®Google Scholar
• Hendrickx H, McEwen BS, Ouderaa F. Metabolism, mood and cognition in aging: the importance of lifestyle and dietary intervention. Neurobiol Aging. 2005;26(Suppl 1):1–5. doi:10.1016/j.neurobiolaging.2005.10.005
   Web of Science ®Google Scholar
• Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–741. doi:10.1016/j.biopsych.2008.11.029
   PubMed Web of Science ®Google Scholar
• Castrén E, Rantamäki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol. 2010;70(5):289–297. doi:10.1002/dneu.20758
   PubMed Web of Science ®Google Scholar
• Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455(7215):894–902. doi:10.1038/nature07455
   PubMed Web of Science ®Google Scholar
• Young JJ, Silber T, Bruno D, Galatzer-Levy IR, Pomara N, Marmar CR. Is there progress? An overview of selecting biomarker candidates for major depressive disorder. Front Psychiatry. 2016;7:72. doi:10.3389/fpsyt.2016.00072
   PubMed Web of Science ®Google Scholar
• Yang C, Wardenaar KJ, Bosker FJ, Li J, Schoevers RA. Inflammatory markers and treatment outcome in treatment resistant depression: a systematic review. J Affect Disord. 2019;257:640–649. doi:10.1016/j.jad.2019.07.045
   PubMed Web of Science ®Google Scholar
• Mora C, Zonca V, Riva MA, Cattaneo A. Blood biomarkers and treatment response in major depression. Expert Rev Mol Diagn. 2018;18(6):513–529. doi:10.1080/14737159.2018.1470927
   PubMed Web of Science ®Google Scholar
• Schmidt HD, Shelton RC, Duman RS. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology. 2011;36(12):2375–2394. doi:10.1038/npp.2011.151
   PubMed Web of Science ®Google Scholar
• Lakhan SE, Vieira K, Hamlat E. Biomarkers in psychiatry: drawbacks and potential for misuse. Int Arch Med. 2010;3:1. doi:10.1186/1755-7682-3-1
   PubMedGoogle Scholar
• Schatzberg AF. Scientific issues relevant to improving the diagnosis, risk assessment, and treatment of major depression. Am J Psychiatry. 2019;176(5):342–347. doi:10.1176/appi.ajp.2019.19030273
   Web of Science ®Google Scholar
• Breitenstein B, Scheuer S, Holsboer F. Are there meaningful biomarkers of treatment response for depression? Drug Discov Today. 2014;19(5):539–561. doi:10.1016/j.drudis.2014.02.002
   Web of Science ®Google Scholar
• Gururajan A, Clarke G, Dinan TG, Cryan JF. Molecular biomarkers of depression. Neurosci Biobehav Rev. 2016;64:101–133. doi:10.1016/j.neubiorev.2016.02.011
   PubMed Web of Science ®Google Scholar
• Brás JP, Pinto S, Almeida MI, et al. Peripheral biomarkers of inflammation in depression: evidence from animal models and clinical studies. Methods Mol Biol. 2019;2011:467–492.
   Google Scholar
• Shi S, Gao Y, Sun Y, et al. The top-100 cited articles on biomarkers in the depression field: a bibliometric analysis. Psychol Health Med. 2020;26:1–10.
   Web of Science ®Google Scholar
• Mac Giollabhui N, Ng TH, Ellman LM, Alloy LB. The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression. Mol Psychiatry. 2020;26(7):3302–3314. doi:10.1038/s41380-020-00867-4
   Web of Science ®Google Scholar
• Su W-J, Cao Z-Y, Jiang C-L. Blocking the trigger: an integrative view on the anti-inflammatory therapy of depression. Brain Behav Immun. 2019;82:10–12. doi:10.1016/j.bbi.2019.09.002
   Web of Science ®Google Scholar
• Brand SJ, Moller M, Harvey BH. A review of biomarkers in mood and psychotic disorders: a dissection of clinical vs preclinical correlates. Curr Neuropharmacol. 2015;13(3):324–368. doi:10.2174/1570159X13666150307004545
   PubMed Web of Science ®Google Scholar
• Redei EE, Andrus BM, Kwasny MJ, et al. Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy. Transl Psychiatry. 2014;4(9):e442. doi:10.1038/tp.2014.66
   PubMed Web of Science ®Google Scholar
• Pajer K, Andrus BM, Gardner W, et al. Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression. Transl Psychiatry. 2012;2(4):e101. doi:10.1038/tp.2012.26
   Web of Science ®Google Scholar
• Hidalgo-Mazzei D, Murru A, Reinares M, Vieta E, Colom F. Big Data in mental health: a challenging fragmented future. World Psychiatry. 2016;15(2):186–187. doi:10.1002/wps.20307
   Web of Science ®Google Scholar
• Li L, Jiang H, Qiu Y, Ching WK, Vassiliadis VS. Discovery of metabolite biomarkers: flux analysis and reaction-reaction network approach. BMC Syst Biol. 2013;7(Suppl2):S13. doi:10.1186/1752-0509-7-S2-S13
   Web of Science ®Google Scholar
• Patel MJ, Khalaf A, Aizenstein HJ. Studying depression using imaging and machine learning methods. Neuroimage Clin. 2016;10:115–123. doi:10.1016/j.nicl.2015.11.003
   PubMed Web of Science ®Google Scholar
• Papakostas GI, Shelton RC, Kinrys G, et al. Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry. 2013;18(3):332–339. doi:10.1038/mp.2011.166
   PubMed Web of Science ®Google Scholar
• Cao ZY, Liu YZ, Li JM, et al. Glycyrrhizic acid as an adjunctive treatment for depression through anti-inflammation: a randomized placebo-controlled clinical trial. J Affect Disord. 2020;265:247–254. doi:10.1016/j.jad.2020.01.048
   Web of Science ®Google Scholar